Arteris (AIP) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and Arteris published the results on November 5, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Arteris reports EPS two ways: GAAP, under the accounting rules every US filer follows, and non-GAAP, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Arteris acquired Cycuity, a hardware security verification company, on January 14, 2026 for about $43.1 million in cash, stock and earn-out. Cycuity's software and U.S. government services revenue has no year-ago equivalent.
• In the Q2 2026 release Arteris guided full-year 2026 revenue of $95.0 million to $98.0 million; the Q3 release raised it to $98.5 million to $99.5 million.

Source: Arteris Q3 2026 results, November 5, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Arteris splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Arteris's Licensing, support and maintenance revenue was $22.4 million in Q3 2026, up 41% from $15.9 million in Q3 2025, 87% of total revenue.
• Arteris's Variable royalties revenue was $2.3 million in Q3 2026, up 52% from $1.5 million in Q3 2025, 9% of total revenue.
• Arteris's Professional services and other revenue was $1.1 million in Q3 2026, up 15786% from $0.0 million in Q3 2025, 4% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

Arteris gives guidance as a table in millions: the first range is Q4 2026 and the second is full year 2026. Free cash flow is guided for the full year only.

In its Q3 2026 release, Arteris said:

“Revenue $25.7-$26.7 $98.5-$99.5”

“ACV + royalties $103.0-$107.0 $103.0-$107.0”

“Non-GAAP operating (loss) income $(0.9)-$1.1 $(9.2) - $(7.2)”

“Free cash flow * $5.0-$9.0”

Source: Arteris Q3 2026 release, Nov 5, 2026.

This is the company's own guidance as of Nov 5, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the AIP forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP total revenue (in millions) and net loss per share, basic and diluted, each as first reported in that quarter's release.

We do not hold a confirmed date for Arteris's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 5, 2026

Arteris licenses network-on-chip interconnect IP and system-on-chip integration software to chip designers. Total revenue was a record $25.8 million in Q3 2026, up 48% from $17.4 million. Licensing, support and maintenance brought in $22.4 million, variable royalties $2.3 million and professional services and other $1.1 million. (Arteris Q3 2026 release, Nov 5, 2026)

Arteris said licensing, support and maintenance revenue rose by $6.5 million on new license arrangements with existing customers, new customers and revenue from hardware security verification products that came with the Cycuity acquisition. Professional services revenue, $1.1 million against $7 thousand, came mainly from hardware security verification services performed for the U.S. government, much of it delivered by subcontractors. (Arteris Form 10-Q, Q3 2026, Nov 5, 2026)

Royalties rise when customers ship more chips that use Arteris IP. Variable royalties grew 52% on higher product sales by existing customers and new customers, and trailing-twelve-months royalties reached $9.4 million, up 71%. Customers confirmed 22 new design starts using Arteris interconnect IP in the quarter, against 23 a year earlier, and Arteris passed 1,000 confirmed design starts since inception. (Arteris Form 10-Q, Q3 2026, Nov 5, 2026; Arteris Q3 2026 release, Nov 5, 2026)

Arteris said one-third of its license wins by dollar value came from top 30 global technology companies, including major deals with a top US hyperscaler, two semiconductor companies and an automotive OEM. One customer, labelled Customer D, accounted for 13% of revenue in Q3 2025; no customer reached 10% in Q3 2026. (Arteris Q3 2026 release, Nov 5, 2026; Arteris Form 10-Q, Q3 2026, Nov 5, 2026)

Arteris' GAAP net loss was $11.2 million, or $0.23 per share, against $9.0 million, or $0.21 per share. Its non-GAAP net loss was $1.1 million, or $0.02 per share, against $0.09. The non-GAAP figures exclude $9.2 million of stock-based compensation, $776 thousand of amortization of acquired intangible assets and $121 thousand of Cycuity acquisition-related costs. (Arteris Q3 2026 release, Nov 5, 2026)

Operating expenses rose to $33.6 million from $24.4 million as headcount grew and Cycuity was added, with general and administrative expenses including a one-time $1.5 million stock award modification charge. GAAP gross margin was 87% against 90%. The tax provision of $845 thousand is mainly foreign withholding and foreign income taxes; Arteris keeps a full valuation allowance on its U.S. deferred tax assets. (Arteris Q3 2026 release, Nov 5, 2026; Arteris Form 10-Q, Q3 2026, Nov 5, 2026)

Weighted average shares rose to 49,384,114 from 42,743,518. Over the first nine months Arteris issued 2,111,123 shares under its at-the-market offering for net proceeds of $72.0 million and 1,096,280 shares for Cycuity. Cash, cash equivalents and short-term investments were $104.2 million at September 30, 2026. (Arteris Q3 2026 release, Nov 5, 2026; Arteris Form 10-Q, Q3 2026, Nov 5, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Arteris guides each quarter on revenue, ACV plus royalties and non-GAAP operating result, plus full-year free cash flow. For Q4 2026 it guided revenue of $25.7 million to $26.7 million and a non-GAAP operating result of $(0.9) million to $1.1 million. For full year 2026 it raised revenue guidance to $98.5 million to $99.5 million and guided ACV plus royalties of $103.0 million to $107.0 million and free cash flow of $5.0 million to $9.0 million. (Arteris Q3 2026 release, Nov 5, 2026)

A consensus figure is the average of the models published by the analysts who cover Arteris, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Arteris's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning AIP is on is AIP a buy or a sell?, what analysts expect next is on the AIP forecast, and what the company does is on the Arteris (AIP) stock page.

Every number on this page can be traced to a document Arteris published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.